Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

NCT03992326 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Internal competitive study that is open

Conditions

Solid Tumor, Adult

Interventions

OTHER: TIL
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2
OTHER: Radiotherapy

Sponsor

Centre Hospitalier Universitaire Vaudois